Top Markets
Coin of the day
InhaleRx Limited InhaleRx Limited

InhaleRx Limited

IRX
Rang in Aktien #35421
Established in 2016 and headquartered in Sydney, Australia, InhaleRx Limited is... Established in 2016 and headquartered in Sydney, Australia, InhaleRx Limited is an Australian company primarily engaged in advancing and bringing to market medical drug delivery systems. The firm also dedicates efforts to developing specialized inhaled drug formulations. A notable product within its portfolio is the Medihale inhaler, a distinctive sealed-pod device engineered for compatibility with its inhaled medications. This entity formerly traded as Lifespot Health Ltd, officially adopting the name InhaleRx Limited in October 2021.
Aktienkurs
$0.01657419
Zuletzt synchronisiert: 2026-03-13
Marktkapitalisierung
$3.93M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-31.14%
Land
AU
Handel InhaleRx Limited (IRX)

Kategorie

Dividendenrendite-Verlauf für InhaleRx Limited (IRX)
Dividendenrendite (TTM) von InhaleRx Limited (Aktienkürzel: IRX) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für InhaleRx Limited (IRX) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber